Preferred Label : Succimer;
NCIt synonyms : Meso 2, 3-Dimercaptosuccinic Acid; DMSA; Butanedioic Acid, 2,3-Dimercapto-, (2R,3S)-rel-;
NCIt definition : An orally active mercaptodicarboxylic acid, with heavy metal chelating activity. As
a strong chelator, succimer is able to bind to heavy metals, such as lead, in the
bloodstream, thereby forming a water-soluble complex that can be eliminated via urinary
excretion. This prevents heavy metal poisoning. In addition, succimer is able to chelate
the alpha particle emitter and radionuclide polonium Po 210 ((Po-210), thereby increasing
its excretion and reducing the toxic effects of Po-210.;
UNII : DX1U2629QE;
InChIKey : ACTRVOBWPAIOHC-XIXRPRMCSA-N;
CAS number : 304-55-2;
Drug name : Chemet;
Chemical formula : C4H6O4S2;
ChEBI ID : CHEBI:63623;
Origin ID : C61953;
UMLS CUI : C0012384;
Automatic exact mappings (from CISMeF team)
Semantic type(s)
UMLS correspondences (same concept)
concept_is_in_subset
https://www.cochrane.org/fr/CD014805/BREASTCA_chimiotherapie-contenant-du-platine-pour-les-femmes-avant-ou-apres-une-intervention-chirurgicale
2023
United Kingdom
review of literature
french abstract
Negative Lymph Node
FGFR1 Gene Mutation Negative
GNA11 Gene Mutation Negative
Pharmacotherapy
ERBB2 Gene Amplification Negative
PAS Negative
Cancer Intervention
ERG Gene Rearrangement Negative
Hepatitis B Virus Core Antibody Negative
neoplasm staging
KIT Negative
women
Woman
Hepatitis B Surface Antibody Negative
platinum, nos
SDHB Negative
neoplasm, malignant
Cisplatin
ANO1 Negative
Polypodium leucotomos Extract
ERBB2 Gene Mutation Negative
platinum
Unmethylated MGMT Gene Promoter
FGFR3 Gene Mutation Negative
Lack of Expression of PD-L1
procedural approach, nos
Contain
FGFR2 Gene Mutation Negative
HRAS Gene Mutation Negative
BAP1 Gene Mutation Negative
Carboplatin
NRAS Gene Mutation Negative
operative procedure, nos
Progesterone Receptor Negative
Chemotherapy
Wnt Negative
KRAS Gene Mutation Negative
triplets
FGFR3 Gene Rearrangement Negative
CDKN2A-p16 Negative
Human Immunodeficiency Virus Negative
PAX8 Gene Rearrangement Negative
Drug Therapy
During or After
CTNNB1 Gene Mutation Negative
FGFR2 Gene Rearrangement Negative
GNAQ Gene Mutation Negative
early
RET Gene Rearrangement Negative
Status Post
Negative Number
ATRX Gene Mutation Negative
Have Not Tried It
1p/19q Codeletion Negative
ESR2 Negative
breast cancer
Surgical Procedure
Epstein-Barr Virus Negative
chemotherapy
10q23/PTEN Locus Deletion Negative
Platinum
SDHA Negative
triple negative breast neoplasms
Negative Charge
Hepatitis B Virus Surface Antigen Negative
TERT Promoter Mutation Negative
BRAF Gene Mutation Negative
Early Stage Breast Carcinoma
ETV Gene Rearrangement Negative
surgical procedures, operative
IDH Family Wildtype
chemotherapy, nos
Succimer
Platinum
CDH1 Gene Mutation Negative
---
https://dumas.ccsd.cnrs.fr/dumas-04414230
2023
France
dissertations, academic
pharmacists
Drug Therapy
Role Entity
Security Role Object
Pharmacotherapy
Management
Prevention Study
Social Role
administration, oral
Effect
pharmacist
Management Occupations
role
Succimer
Chemotherapy
chemotherapy
NCI Thesaurus Role
chemotherapy, nos
Preventive Intervention
Prevention
Oral Route of Administration
---
https://www.arcagy.org/infocancer/localisations/appareil-digestif/cancer-oesophage/traitements/la-chimioth-rapie-et-l-immunoth-rapie.html/
2023
France
popular works
BPIFA1 wt Allele
Lung
lung
Drug Therapy
Cancer Immunotherapy
immunotherapy
chemotherapy, nos
chemotherapy
UNG Gene
immunotherapy, nos
Succimer
Uracil-DNA Glycosylase
Murine Lung
---
https://www.cochrane.org/fr/CD013774/PROSTATE_limmunotherapie-par-rapport-la-chimiotherapie-pour-le-traitement-du-cancer-de-la-vessie-inoperable
2023
United Kingdom
review of literature
french abstract
urinary bladder cancer
Metastatic Malignant Neoplasm
urinary bladder neoplasms
chemotherapy, nos
chemotherapy
Cancer Immunotherapy
Childhood Bladder Carcinoma
Drug Therapy
albumin/globulin ratio
research report
immunotherapy for cancer
immunotherapy
Bladder Cancer Pathway
Ratio
Cancer Therapeutic Procedure
Succimer
Regulatory Report
malignant neoplasm of bladder
---